Huang X - Search Results

1

Simulating the interactions of toxins with K+ channels.

Huang X, Liu H, Cui M, Fu W, Yu K, Chen K, Luo X, Shen J, Jiang H. Huang X, et al. Curr Pharm Des. 2004;10(9):1057-67. doi: 10.2174/1381612043452776. Curr Pharm Des. 2004. PMID: 15078133 Review.

2

Brownian dynamics simulations of the recognition of the scorpion toxin maurotoxin with the voltage-gated potassium ion channels.

Fu W, Cui M, Briggs JM, Huang X, Xiong B, Zhang Y, Luo X, Shen J, Ji R, Jiang H, Chen K. Fu W, et al. Among authors: huang x. Biophys J. 2002 Nov;83(5):2370-85. doi: 10.1016/S0006-3495(02)75251-X. Biophys J. 2002. PMID: 12414674 Free PMC article.

3

Molecular dynamics simulations on SDF-1alpha: binding with CXCR4 receptor.

Huang X, Shen J, Cui M, Shen L, Luo X, Ling K, Pei G, Jiang H, Chen K. Huang X, et al. Biophys J. 2003 Jan;84(1):171-84. doi: 10.1016/S0006-3495(03)74840-1. Biophys J. 2003. PMID: 12524273 Free PMC article.

4

New p-methylsulfonamido phenylethylamine analogues as class III antiarrhythmic agents: design, synthesis, biological assay, and 3D-QSAR analysis.

Liu H, Ji M, Luo X, Shen J, Huang X, Hua W, Jiang H, Chen K. Liu H, et al. Among authors: huang x. J Med Chem. 2002 Jul 4;45(14):2953-69. doi: 10.1021/jm010574u. J Med Chem. 2002. PMID: 12086482

5

Inhibitory mode of 1,5-diarylpyrazole derivatives against cyclooxygenase-2 and cyclooxygenase-1: molecular docking and 3D QSAR analyses.

Liu H, Huang X, Shen J, Luo X, Li M, Xiong B, Chen G, Shen J, Yang Y, Jiang H, Chen K. Liu H, et al. Among authors: huang x. J Med Chem. 2002 Oct 24;45(22):4816-27. doi: 10.1021/jm020089e. J Med Chem. 2002. PMID: 12383007

6

Molecular docking and 3D-QSAR studies on gag peptide analogue inhibitors interacting with human cyclophilin A.

Cui M, Huang X, Luo X, Briggs JM, Ji R, Chen K, Shen J, Jiang H. Cui M, et al. Among authors: huang x. J Med Chem. 2002 Nov 21;45(24):5249-59. doi: 10.1021/jm020082x. J Med Chem. 2002. PMID: 12431052

7

Conformational flexibility of beta-secretase: molecular dynamics simulation and essential dynamics analysis.

Xiong B, Huang XQ, Shen LL, Shen JH, Luo XM, Shen X, Jiang HL, Chen KX. Xiong B, et al. Among authors: huang xq. Acta Pharmacol Sin. 2004 Jun;25(6):705-13. Acta Pharmacol Sin. 2004. PMID: 15169620 Free article.

8

Discovery of Potent and Selective Agonists of δ Opioid Receptor by Revisiting the "Message-Address" Concept.

Shen Q, Qian Y, Huang X, Xu X, Li W, Liu J, Fu W. Shen Q, et al. Among authors: huang x. ACS Med Chem Lett. 2016 Feb 10;7(4):391-6. doi: 10.1021/acsmedchemlett.5b00423. eCollection 2016 Apr 14. ACS Med Chem Lett. 2016. PMID: 27096047 Free PMC article.

9

Development of quantitative structure-activity relationships and its application in rational drug design.

Yang GF, Huang X. Yang GF, et al. Among authors: huang x. Curr Pharm Des. 2006;12(35):4601-11. doi: 10.2174/138161206779010431. Curr Pharm Des. 2006. PMID: 17168765 Review.

10

Modeling subtype-selective agonists binding with alpha4beta2 and alpha7 nicotinic acetylcholine receptors: effects of local binding and long-range electrostatic interactions.

Huang X, Zheng F, Chen X, Crooks PA, Dwoskin LP, Zhan CG. Huang X, et al. J Med Chem. 2006 Dec 28;49(26):7661-74. doi: 10.1021/jm0606701. J Med Chem. 2006. PMID: 17181149

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47,424 results

Search Page

Filters